Andreas Calatzis: Great to See MultiClot on The Booth!
Andreas Calatzis, Managing Director of Eonis GmbH, reposted from Quirin Hipp on LinkedIn:
”Great to see MultiClot on the booth!
If you are a product guy, this is the second-best event (after seeing products in customer´s hands).
For me a product is something magical and true, better than publications, awards or anything else (aside from many magical things in the private life of course).
It is great to create things, that move people and that are used by real people in their everyday work.
Thank you for sharing!”
Quoting Quirin Hipp‘s post:
”Visit us at the DIVI Congress: You will find us in Hall H, Booth HD-14, directly opposite the e-poster area.
Together with our Austrian distribution partner EKOMED, we will be presenting the MultiClot system.
We look forward to talking to you!”
Stay updated with Hemostasis Today.
-
Aug 15, 2026, 19:30José Luis Neyro: E4 and DRSP Reduce Hirsutism While Showing Comparable Effects on Thrombin Generation
-
Aug 15, 2026, 19:27Mahmoud Akraym: Don’t Choose Anticoagulation as the Immediate Treatment for Unstable AF
-
Aug 15, 2026, 19:25Ahmed Bennis: DOACs Increase 1-Year Stroke Risk but Reduce MI Risk Compared With Warfarin
-
Aug 15, 2026, 19:24Megan Adediran: An Unwavering Fight for People Living With Haemophilia
-
Aug 15, 2026, 19:23Intravenous Anticoagulation Linked to Worse Early Outcomes After Noncardioembolic Stroke – International Journal of Stroke
-
Aug 15, 2026, 18:03Alejandro González Veliz: Pulmonary Embolism Is Not Always an Anticoagulation-Only Problem
-
Aug 15, 2026, 17:57Ayesha Zia: A New Foundation for Pediatric Pulmonary Embolism Research and Care
-
Aug 15, 2026, 17:50Muhammad Shaheer Bin Faheem: 25 Years of Thromboembolism and Hypertension Mortality
-
Aug 15, 2026, 17:21Bilal Salman։ NETosis as a Therapeutic Target in Inflammation and Thrombosis